The key to the good management of irritable bowel syndrome (lES) is a positive attitude to both diagnosis and treatment. It should be explained to patients that they do indeed have a legitimate disorder and they should never be told there is nothing wrong with them. Appropriate investigations such as ultrasonography, endoscopy, or bari um studies may be necessary depending on the clinical situation. However, the patient should be forewarned that a negative result is anticipated as the purpose of the test is to exclude other possible diseases rather than to help with the diagnosis of their disorder. In other words an absence of demonstrable pathology does not detract from the reality of their problem.
The temptation to classify as IBS all gastrointestinal symptoms that cannot be satisfactorily explained should be avoided. Patients should fulfil diagnostic criteria based on symptoms of which the three most important are abdominal pain (any site), abdominal distension and an abnormal bowel habit. Close questioning about the bowel habit may be necessary. For instance one visit to the toilet a day to open the bowels may not sound particularly abnormal but if that visit lasts over an hour it is clearly far from normal. Conversely 10 visits a day may sound like diarrhoea but if only a few small, hard pellets are expelled at each visit this would be better classified as constipation or frequent defaecation. It remains to be determined whether conditions such as non-ulcer dyspepsia, biliary dyskinesia, oesophageal spasm, proctalgia fugax and slow transit constipation form part of the spectrum of IBS or are separate entities.
Irritable bowel syndrome is exceedingly common and affects at least 15% of the population'. The sex incidence varies from series to series but most indicate a female preponderance. The condition shows a familial pattern'' but whether this indicates a genetic predisposition or is a reflection of environmental factors remains to be determined. The cause is entirely unknown but autonomic or neuroendocrine dysfunction may be involved. It is not an uncommon clinical observation for lES to appear to be precipitated by gastrointestinal infections, antibiotic usage or abdominal (particularly gynaecological) surgery. The question of food intolerance remains highly controversial. A particularly difficult issue is the role of stress and psychological factors in the pathogenesis ofIBS. Stress certainly has an exacerbating influence and there is no doubt that in most series the incidence of psychopathology is in the order of 50-60%3. The problem is that these studies have all been on hospitalbased populations raising questions such as cause or effect and selection bias. Two recent studies have examined the incidence of psychopathology in IBS subjects in the community who had not sought medical advice''>, Interestingly the prevalence of psychopathology in these subjects was no greater than that of unaffected individuals.
It is now generally believed that whatever the cause, lES represents a motility disorder of the whole gut rather than just the colon. Abnormal motility patterns have been described in the oesophagus", small bowel'-", large bowelv-", and anorectum!'. In addition bladder smooth muscle abnormalities have been describedt-suggesting that IBS may represent an even more diffuse disorder of smooth muscle or its innervation. In contrast visceral sensitivity has received relatively little attention but there is some evidence for it being increased in patients with IBSl3,14. Somatic pain tolerance is greater in IBSl5 subjects than normals indicating that they are not just chronic complainers. Thus both motility and visceral sensitivity appear to be disturbed in IBS and the relative contribution of each from patient to patient may be variable. The science of motility is rapidly advancing and it may not be too long before we have motility tests which significantly contribute to the more accurate diagnosis of IBS.
The fact that IBS is a more generalized disorder of the gastrointestinal tract than previously appreciated may partly explain why patients complain of such symptom diversity. It has recently been shown that the following 'non-colonic' symptoms are particularly prominent-": nausea, heartburn, early satiety, dyspareunia, urinary frequency and urgency, nocturia, constant lethargy, backache and thigh pain. These symptoms are of major practical importance as patients can often cope with them much better if they know that they are associated with their problem and are not indicative of more serious disease. In addition ignorance of these symptoms can lead to much unnecessary investigation and referral to inappropriate specialties. In particular patients with IBS are frequently referred to gynaecological clinics!".
After the explanations outlined earlier the mainstays of treatment are bulking agents and anti-spasmodics. Bran can sometimes exacerbate a patient's symptoms and the ispaghula derivatives, particularly the modern flavoured ones, are often a more satisfactory way of providing bulk in the diet. There are many anti-spasmodic drugs available and if one does not work it is always worth trying alternatives. The 'as necessary' use of these agents is often preferable as it prevents tachyphylaxis and also maintains the placebo effect of taking a tablet for the pain. Antidiarrhoeal agents are useful in patients with true diarrhoea but are contra-indicated in the frequent defaecators mentioned earlier who do better with overall'".
In summary many patients with IBS can be improved by a positive approach to management coupled with careful selection of appropriate medications. For those patients who prove refractory to therapy we usually first investigate them more fully and assess their gastrointestinal motility. lfno other problems are found we try transcutaneous nerve stimulation for the pain predominant individuals and exclusion diets for those with a loose bowel habit. Hypnotherapy, because it is the most time consuming of all the options, is reserved for those in whom all other treatments have failed.
